INFECTIOUS DISEASE

Diabetes and Insulin Resistance

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Diabetes and Insulin Resistance

Chapter 71 Diabetes and Insulin Resistance Colleen Hadigan, MD, MPH, Steven Grinspoon, MD INTRODUCTION Insulin resistance and type 2 diabetes mellitus are increasingly recognized as common among individuals with HIV…

read more

Varicella-Zoster Virus Infections

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Varicella-Zoster Virus Infections

Chapter 49 Varicella-Zoster Virus Infections John W. Gnann, Jr, MD Diseases caused by all human herpesviruses, including varicella-zoster virus (VZV), occur with increased frequency in patients with human immunodeficiency virus…

read more

Efavirenz

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Efavirenz

Chapter 14 Efavirenz Schlomo Staszewski, MD Efavirenz (EFV, Sustiva) is a human immunodeficiency virus type 1 (HIV-1) specific, non-nucleoside reverse transcriptase inhibitor (NNRTI). EFV is a noncompetitive inhibitor of HIV-1…

read more

Kaposi Sarcoma

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Kaposi Sarcoma

Chapter 59 Kaposi Sarcoma Susan E. Krown, MD Kaposi sarcoma (KS) was one of the first opportunistic diseases described in association with the acquired immune deficiency syndrome (AIDS).1 Despite a…

read more

Mycoses Caused by Molds

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Mycoses Caused by Molds

Chapter 47 Mycoses Caused by Molds Thomas F. Patterson, MD, John R. Graybill, MD Infections caused by molds are uncommon but important causes of opportunistic infections in patients with advanced…

read more

Fosamprenavir and Amprenavir

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Fosamprenavir and Amprenavir

Chapter 19 Fosamprenavir and Amprenavir Roger Paredes, MD, Lidia Ruiz, PhD, Bonaventura Clotet, MD, PhD INTRODUCTION Protease inhibitors (PIs) are one of the mainstays of HIV/AIDS therapy,1 being largely responsible…

read more

Cryptococcosis

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Cryptococcosis

Chapter 43 Cryptococcosis Judith A. Aberg, MD, William G. Powderly, MD Disseminated cryptococcosis has been the most common life-threatening fungal infection in patients with acquired immunodeficiency syndrome (AIDS), affecting up…

read more

Lopinavir

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Lopinavir

Chapter 20 Lopinavir Steven C. Johnson, MD, Daniel R. Kuritzkes, MD Lopinavir (formerly known as ABT-378) was the first of the ‘second-generation’ protease inhibitors (PIs) to be approved for clinical…

read more

Herpes Simplex Virus Infections

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Herpes Simplex Virus Infections

Chapter 48 Herpes Simplex Virus Infections Kimberly Y. Smith, MD, MPH, Harold A. Kessler, MD PATHOGEN Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are common pathogens in…

read more

Saquinavir

Aug 11, 2016 by in INFECTIOUS DISEASE Comments Off on Saquinavir

Chapter 15 Saquinavir Anton Posniak, MD, FRCP, Kasha P. Singh, MBBS, FRACP INTRODUCTION On the 4 December 1997, the Society for Medicines Research Award for Drug Discovery was presented to…

read more
Get Clinical Tree app for offline access